Zobrazeno 1 - 10
of 7 379
pro vyhledávání: '"Benjamin Rs"'
Autor:
Bishop AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mitra D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Farooqi A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Swanson DM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hempel C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Willis T; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pearlnath C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ratan R; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Somaiah N; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Benjamin RS; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Torres KE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hunt KK; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Scally CP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Satcher RL; Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bird JE; Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lin PP; Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Moon BS; Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lewis VO; Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Roland CL; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Guadagnolo BA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Cancer [Cancer] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.
Autor:
Patel RR; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, |1515 Holcombe Blvd., Houston, TX 77030, USA.; Division of Epidemiology, The University of Texas School of Public Health, 1200 Pressler St., Houston, TX 77030, USA., Gopalakrishnan V; Division of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA., Amini B; Division of Diagnostic Radiology-Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA., Lin PP; Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA., Benjamin RS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, |1515 Holcombe Blvd., Houston, TX 77030, USA., Bishop AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA., Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA., Araujo DM; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, |1515 Holcombe Blvd., Houston, TX 77030, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Dec 09; Vol. 16 (23). Date of Electronic Publication: 2024 Dec 09.
Autor:
Valenzuela RF; Department of Musculoskeletal Imaging, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Duran-Sierra E; Department of Musculoskeletal Imaging, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Canjirathinkal M; Department of Musculoskeletal Imaging, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Amini B; Department of Musculoskeletal Imaging, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Torres KE; Department of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Benjamin RS; Department of Sarcoma Medical Oncology, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Ma J; Department of Imaging Physics, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Wang WL; Department of Anatomical Pathology, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Hwang KP; Department of Imaging Physics, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Stafford RJ; Department of Imaging Physics, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Wu C; Department of Imaging Physics, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Zarzour AM; Department of Sarcoma Medical Oncology, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Bishop AJ; Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Lo S; Department of Musculoskeletal Imaging, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Madewell JE; Department of Musculoskeletal Imaging, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Kumar R; Department of Musculoskeletal Imaging, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Murphy WA Jr; Department of Musculoskeletal Imaging, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA., Costelloe CM; Department of Musculoskeletal Imaging, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1475, Houston, TX, 77030-4009, USA.
Publikováno v:
Scientific reports [Sci Rep] 2024 Sep 17; Vol. 14 (1), pp. 21681. Date of Electronic Publication: 2024 Sep 17.
Autor:
Benjamin RS; From the Department of Sarcoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2024 Sep 05; Vol. 391 (9), pp. 854-855.
Autor:
Patel RR; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center.; Department of Epidemiology., Delclos GL; Department of Environmental and Occupational Health Sciences., DeSantis SM; Department of Biostatistics, The UTHealth Houston School of Public Health., Cannell MB; Department of Epidemiology., Lupo PJ; Department of Pediatrics, Baylor College of Medicine., Bishop AJ; Department of Radiation Oncology., Lazar AJ; Department of Pathology.; Department of Genomic Medicine., Lin PP; Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Benjamin RS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center., Patel SR; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center., Ludwig J; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center., Ravi V; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center., Livingston JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center., Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center., Zarzour MA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center., Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center., Araujo DM; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center.
Publikováno v:
American journal of clinical oncology [Am J Clin Oncol] 2024 Sep 03. Date of Electronic Publication: 2024 Sep 03.
Autor:
Nakazawa MS; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Livingston JA; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zarzour MA; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bishop AJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ratan R; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ludwig JA; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Araujo DM; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Somaiah N; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravi V; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nassif EF; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Roland CL; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lazar AJ; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Guadagnolo BA; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Harrison DJ; Department of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Benjamin RS; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel SR; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Conley AP; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Rare tumors [Rare Tumors] 2024 Aug 04; Vol. 16, pp. 20363613241271669. Date of Electronic Publication: 2024 Aug 04 (Print Publication: 2024).
Autor:
Benjamin RS; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.; Archie's Cochlear Implant Laboratory, Hospital for Sick Children, Toronto, Ontario, Canada., Cushing SL; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.; Archie's Cochlear Implant Laboratory, Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Otolaryngology, Head and Neck Surgery, Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Otolaryngology, Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada., Blakeman AW; Archie's Cochlear Implant Laboratory, Hospital for Sick Children, Toronto, Ontario, Canada., Campos JL; Department of Psychology, University of Toronto, Toronto, Ontario, Canada.; KITE, Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada., Papsin BC; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.; Archie's Cochlear Implant Laboratory, Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Otolaryngology, Head and Neck Surgery, Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Otolaryngology, Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada., Gordon KA; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.; Archie's Cochlear Implant Laboratory, Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Otolaryngology, Head and Neck Surgery, Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Otolaryngology, Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada.; Department of Communication Disorders, Hospital for Sick Children, Toronto, Ontario, Canada.
Publikováno v:
Ear and hearing [Ear Hear] 2024 Mar-Apr 01; Vol. 45 (2), pp. 378-389. Date of Electronic Publication: 2023 Sep 28.
Autor:
Thirasastr P; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sutton TL; Division of Surgical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University School of Medicine, Portland, OR 97239, USA., Joseph CP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lin H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Amini B; Department of Musculoskeletal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Mayo SC; Division of Surgical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University School of Medicine, Portland, OR 97239, USA., Araujo D; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Benjamin RS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Livingston JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ludwig J; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Patel S; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ratan R; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ravi V; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zarzour MA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Nassif Haddad EF; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Nakazawa MS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhou X; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Heinrich MC; Cell and Developmental Biology, OHSU Knight Cancer Institute, Oregon Health & Science University School of Medicine, Portland, OR 97239, USA., Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Feb 23; Vol. 16 (5). Date of Electronic Publication: 2024 Feb 23.
Autor:
Benjamin RS; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.; Archie's Cochlear Implant Laboratory, Hospital for Sick Children, Toronto, ON, Canada., Cushing SL; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.; Archie's Cochlear Implant Laboratory, Hospital for Sick Children, Toronto, ON, Canada.; Department of Otolaryngology, Head and Neck Surgery, Hospital for Sick Children, Toronto, ON, Canada.; Department of Otolaryngology, Head and Neck Surgery, University of Toronto, Toronto, ON, Canada., Blakeman AW; Archie's Cochlear Implant Laboratory, Hospital for Sick Children, Toronto, ON, Canada., Campos JL; Department of Psychology, University of Toronto, Toronto, ON, Canada.; KITE, Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada., Papsin BC; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.; Archie's Cochlear Implant Laboratory, Hospital for Sick Children, Toronto, ON, Canada.; Department of Otolaryngology, Head and Neck Surgery, Hospital for Sick Children, Toronto, ON, Canada.; Department of Otolaryngology, Head and Neck Surgery, University of Toronto, Toronto, ON, Canada., Gordon KA; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada. karen.gordon@utoronto.ca.; Archie's Cochlear Implant Laboratory, Hospital for Sick Children, Toronto, ON, Canada. karen.gordon@utoronto.ca.; Department of Otolaryngology, Head and Neck Surgery, Hospital for Sick Children, Toronto, ON, Canada. karen.gordon@utoronto.ca.; Department of Otolaryngology, Head and Neck Surgery, University of Toronto, Toronto, ON, Canada. karen.gordon@utoronto.ca.; Department of Communication Disorders, Hospital for Sick Children, Toronto, ON, Canada. karen.gordon@utoronto.ca.
Publikováno v:
Scientific reports [Sci Rep] 2023 Jun 15; Vol. 13 (1), pp. 9721. Date of Electronic Publication: 2023 Jun 15.
Autor:
Carmagnani Pestana R; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Hospital Israelita Albert Einstein, São Paulo, Brazil., Moyers JT; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Medicine, Division of Hematology and Oncology, The University of California, Irvine, Orange, California., Roszik J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sen S; Sarah Cannon Research Institute, Nashville, Tennessee., Hong DS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Naing A; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Herzog CE; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fu S; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Piha-Paul SA; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Rodon J; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Yap TA; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Karp DD; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Tsimberidou AM; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Pant S; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Zarzour MA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ratan R; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravi V; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Benjamin RS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daw N; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gill JB; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Harrison DJ; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lewis VO; Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Roland CL; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel SR; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Livingston JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ludwig JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hamerschlak N; Hospital Israelita Albert Einstein, São Paulo, Brazil., Gorlick R; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Subbiah V; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 May 01; Vol. 29 (9), pp. 1708-1718.